http://www.cytokinetics.com
Cytokinetics, Incorporated Company Intro
Cytokinetics develops first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised.
Industry
Healthcare
Cytokinetics, Incorporated Headquaters
280 East Grand Avenue
South San Francisco,94080
United States
Cytokinetics, Incorporated Share price
14 Sep 2022 09:02 GMT
$52.80
-1.66 (-3.05 %)
Cytokinetics, Incorporated Market cap
$4.511 B
WMC RANKING
2022
Cytokinetics, Incorporated # 96
BiotechnologyLatest Cytokinetics, Incorporated News
06 Dec 2022
Cytokinetics, Incorporated (NASDAQ:CYTK) CEO Robert I ...
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as...
06 Dec 2022
JPMorgan Chase & Co. Has $9.16 Million Position in ...
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as...
06 Dec 2022
Should Investors Worry About Cytokinetics Inc's Insider Sells?
The latest data from GuruFocus shows that President & CEO Robert Blum sold 10000 shares of Cytokinetics Inc (CYTK) on 2022-12-05. 0C00000AUW.png.
WMC Market Score
WMC Market to Revenue Score
Cytokinetics, Incorporated Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Cytokinetics, Incorporated | USD | $58,551 | $162,743 | $-134,989 | $45,110B | 96 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Cytokinetics, Incorporated Social Followers vs Top 4 Industry Competitors
Cytokinetics, Incorporated Post vs Top 4 Industry Competitors
Cytokinetics, Incorporated Digital Footprint By Size vs Top 4 Industry Competitors
Cytokinetics, Incorporated Digital Footprint By Change Rate vs Top 4 Industry Competitors
Cytokinetics, Incorporated WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Cytokinetics, Incorporated | 0.64 | 4.44 | 0.05 | 0 | 0 | 0 | 2.03 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
